ArticleJAC-antimicrobial resistance2026
Understanding veterinarians' antibiotic choices and eliciting acceptable non-inferiority margins for randomized trials: a multi-country study.
Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Unnecessary antibiotic use is a problem in both human and veterinary medicine. A clear understanding of prescribing behaviours and the underlying drivers is required to design studies that can provide the necessary evidence to identify areas or populations where antibiotics can safely be reduced. Methods: We conducted three discrete choice experiments to evaluate prescribing behaviour in different clinical scenarios where antibiotics are frequently part of case management: canine acute diarrhoea (CAD), post-operative prophylaxis (SAP), and urinary tract infection (UTI). We estimated acceptable non-inferiority margins for clinical trials (i.e. the maximum outcome loss clinicians would accept in exchange for reduced antibiotic use) for CAD and UTI. A total of 1219 small animal veterinarians across six global regions were surveyed. Results: Key drivers of prescribing behaviour included severity of clinical signs (CAD), anticipated clinical and microbiological cure rate (UTI), and risk of surgical site infection (SAP). Client pressure also impacted on prescribing decisions in all scenarios. In two of three scenarios, CAD and UTI, potentially acceptable non-inferiority margins were identified: 0-2 days for CAD duration without antibiotics; and 10% for clinical and microbiological cure in UTI cases. We found substantial geographical variation in prescribing habits, with higher rates in Asia and Southern/Eastern Europe. Conclusions: Results highlight problematic areas for targeting reduction measures but should support the development of antimicrobial stewardship guidelines aiming to reduce unnecessary antibiotic use.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.